ARCHIVES

Scrutiny of caBIG Exposes Conflicts, Bonanza For Contractors

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | March 18, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Oncology Division Director Says Goal to Make Review Process “Predictable”

August 2, 1996

FDA Selects 23 Survivors To Review Drug Applications.

June 15, 2001

In Brief: Univ. of New Mexico Looked Over As Possible Comprehensive Center; Missouri Asks Delay

November 26, 1976

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

Elevated Baseline Glucose Levels Associated With Higher Cancer Risk

November 25, 2011

Arthur Upton Will Be New NCI Director; Colleagues Convinced He’ll Be strong Leader

June 10, 1977